Ivermectin Study’s Negative Conclusion is at Odds With Its Findings of Significant Clinical Benefit

Will Jones

A new study on cheap, repurposed Covid treatment ivermectin has concluded that its findings “do not support the use of ivermectin to treat mild to severe forms of COVID-19”. However, this conclusion is at odds with its findings.

… The study is a follow-up to an earlier, smaller study which showed promise. However, the promise has not, the authors say, been borne out.

… Despite this downbeat assessment, the new study did actually find a significant 32% improvement in ivermectin hospital patients achieving complete recovery, with 37% of ivermectin patients vs 28% of placebo patients achieving the outcome.

Latest articles

William J. Walsh Each of us has innate biochemical factors which influence...
Joanna Moncrieff et al. The serotonin hypothesis of depression is still influential....
Raymond J. Pataracchia Biochemical syndromes of importance in mood and behaviour disorders...
Orthomolecular Medicine News Service Doctors report that mental health problems including depression,...
David R. Hawkins et al. Over the years a great many biochemical...
A Midwestern Doctor Many people believe the most significant issues facing the...

Thank you!

Thank you for your membership application. As soon as your payment has been received your membership will be activated and you will be informed via email.

Thank you.

Thank you!

The form has been submitted successfully!